The Breast Cancer Association Consortium (BCAC) recently reported that ER positive patients, homozygous for the risk allele, had poorer overall and breast cancer specific survival than patients, homo- and heterozygous for the non-risk allele[40]. The gene discussed is ESR1; the disease is breast cancer.